SCHEMBL7444527

SCHEMBL7444527

Cn1ccnc1CCc1ccc(C#N)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNJ1 P48048 2/20 0.46
KCNH2 Q12809 2/20 0.46
GAA P10253 1/20 0.45
CYP19A1 P11511 5/20 0.42
CYP11B1 P15538 2/20 0.42
CYP11B2 P19099 2/20 0.42
CYP2A6 P11509 1/20 0.42
HSP90AA1 P07900 1/20 0.42
HSP90B1 P14625 1/20 0.42
NSD2 O96028 1/20 0.41
LOXL2 Q9Y4K0 2/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TBXAS1 P24557 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4464649 0.79 KMT2A (0.40) TSHRHSD17B10MEN1KMT2A
SCHEMBL3401058 0.78 KMT2A (0.53) HSP90AA1MEN1KMT2A
SCHEMBL7442310 0.78 MEN1 (0.62) GAACYP19A1TSHRHSD17B10MEN1
SCHEMBL7393515 0.77 CDC7 (0.39) GAAHSP90AA1HSP90B1TSHRMEN1
SCHEMBL7446567 0.76 TRPM5 (0.51) GAACYP19A1CYP11B1CYP11B2LOXL2
SCHEMBL8327597 0.76 TSHR (0.41) KCNJ1KCNH2GAACYP19A1CYP11B1
Bromide SCHEMBL29657458 0.75 FDPS (0.47) TSHRMEN1KMT2A
SCHEMBL1474745 0.74 TBXAS1 (0.49) MEN1KMT2ATBXAS1
SCHEMBL14611686 0.74 HMOX1 (0.56) KCNH2MEN1KMT2A
SCHEMBL1004267 0.73 LOXL2 (0.64) KCNJ1KCNH2CYP19A1CYP2A6LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1088702-C Disubstituted bicyclic heterocycles, their production and use as medicaments BOEHRINGER INGELHEIM PHARMA (DE) 2002-08-07 CN disclosed
CN-1248251-A Disubstituted bicyclic heterocycles, their production and use as medicaments BOEHRINGER INGELHEIM PHARMA (DE) 2000-03-22 CN disclosed
EP-0966454-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES, THEIR PRODUCTION AND USE AS MEDICAMENTS Boehringer Ingelheim Pharma KG (DE) 1999-12-29 EP disclosed
WO-1998037075-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES, THEIR PRODUCTION AND USE AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 1998-08-27 WO disclosed